D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 106 Citations 33,468 647 World Ranking 2935 National Ranking 1685
Best female scientists D-index 106 Citations 33,471 966 World Ranking 687 National Ranking 426

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Her scientific interests lie mostly in Internal medicine, Multiple myeloma, Surgery, Gastroenterology and Amyloidosis. Her Internal medicine and Transplantation, Survival rate, Hematology, Dexamethasone and Survival analysis investigations all form part of her Internal medicine research activities. Her Transplantation research integrates issues from Plasma cell dyscrasia, Total body irradiation, Stem cell, POEMS syndrome and Organomegaly.

Her research integrates issues of Monoclonal gammopathy of undetermined significance and Pathology in her study of Multiple myeloma. Her biological study spans a wide range of topics, including Pomalidomide, Neutropenia, Immunology, Hazard ratio and Myeloma protein. Her Amyloidosis study integrates concerns from other disciplines, such as AL amyloidosis, Immunoglobulin Light-chain Amyloidosis, Hematologic Response, Nephrotic syndrome and Primary systemic amyloidosis.

Her most cited work include:

  • POEMS syndrome: definitions and long-term outcome. (560 citations)
  • Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial (556 citations)
  • Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines (469 citations)

What are the main themes of her work throughout her whole career to date?

Martha Q. Lacy focuses on Internal medicine, Multiple myeloma, Surgery, Gastroenterology and Oncology. Her work in Transplantation, Amyloidosis, Lenalidomide, Autologous stem-cell transplantation and Dexamethasone is related to Internal medicine. The study incorporates disciplines such as Survival analysis and Bone marrow, Pathology in addition to Multiple myeloma.

Her studies deal with areas such as Cohort and Primary systemic amyloidosis as well as Surgery. Her Gastroenterology research is multidisciplinary, relying on both Survival rate, Progression-free survival, Retrospective cohort study and Hazard ratio. Martha Q. Lacy interconnects Hematology, Newly diagnosed and Clinical trial in the investigation of issues within Oncology.

She most often published in these fields:

  • Internal medicine (69.53%)
  • Multiple myeloma (56.58%)
  • Surgery (33.89%)

What were the highlights of her more recent work (between 2017-2021)?

  • Internal medicine (69.53%)
  • Multiple myeloma (56.58%)
  • Oncology (24.56%)

In recent papers she was focusing on the following fields of study:

Martha Q. Lacy spends much of her time researching Internal medicine, Multiple myeloma, Oncology, Gastroenterology and AL amyloidosis. Her study in the field of Lenalidomide also crosses realms of In patient. She works mostly in the field of Oncology, limiting it down to concerns involving Waldenstrom macroglobulinemia and, occasionally, Rituximab.

Her research in Gastroenterology intersects with topics in Progression-free survival, Overall survival, Survival rate, Hazard ratio and Stage. Her AL amyloidosis study integrates concerns from other disciplines, such as Proteinuria and Melphalan. To a larger extent, she studies Surgery with the aim of understanding Transplantation.

Between 2017 and 2021, her most popular works were:

  • Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline. (92 citations)
  • Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria. (84 citations)
  • Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time (53 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Martha Q. Lacy mostly deals with Internal medicine, Multiple myeloma, Gastroenterology, AL amyloidosis and Amyloidosis. Internal medicine is closely attributed to Oncology in her study. Her Multiple myeloma research integrates issues from Stage, Newly diagnosed, Survival analysis and Hazard ratio.

Martha Q. Lacy has included themes like Odds ratio, Waldenstrom macroglobulinemia, Multivariate analysis, Cyclophosphamide and Kidney in her Gastroenterology study. The various areas that Martha Q. Lacy examines in her AL amyloidosis study include Survival rate, Cardiology, Proteinuria and Urology. Her studies in Transplantation integrate themes in fields like Stem cell and Lenalidomide.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

POEMS syndrome: definitions and long-term outcome.

Angela Dispenzieri;Robert A. Kyle;Martha Q. Lacy;S. Vincent Rajkumar.
Blood (2003)

832 Citations

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

Jesús Fernando San Miguel;Jesús Fernando San Miguel;Katja Weisel;Philippe Moreau;Martha Lacy.
Lancet Oncology (2013)

788 Citations

Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

Shaji K. Kumar;Joseph R. Mikhael;Francis K. Buadi;David Dingli.
Mayo Clinic Proceedings (2009)

491 Citations

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.

Angela Dispenzieri;Morie A. Gertz;Robert A. Kyle;Martha Q. Lacy.
Blood (2004)

395 Citations

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.

Luis F. Porrata;Morie A. Gertz;David J. Inwards;Mark R. Litzow.
Blood (2001)

392 Citations

Clinical course of patients with relapsed multiple myeloma.

Shaji K. Kumar;Terry M. Therneau;Morie A. Gertz;Martha Q. Lacy.
Mayo Clinic proceedings (2004)

370 Citations

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study.

Paul G. Richardson;David S. Siegel;Ravi Vij;Craig C. Hofmeister.
Blood (2014)

346 Citations

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.

Angela Dispenzieri;Martha Q. Lacy;Steven R. Zeldenrust;Suzanne R. Hayman.
Blood (2007)

339 Citations

Mayo Clinic Consensus Statement for the Use of Bisphosphonates in Multiple Myeloma

Martha Q. Lacy;Angela Dispenzieri;Morie A. Gertz;Philip R. Greipp.
Mayo Clinic Proceedings (2006)

314 Citations

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.

C S Debes-Marun;G W Dewald;S Bryant;E Picken.
Leukemia (2003)

308 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Martha Q. Lacy

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 251

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 211

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 208

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 205

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 204

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 189

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 189

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 166

Giampaolo Merlini

Giampaolo Merlini

University of Pavia

Publications: 156

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 155

Robert A. Kyle

Robert A. Kyle

Mayo Clinic

Publications: 150

Pieter Sonneveld

Pieter Sonneveld

Erasmus University Rotterdam

Publications: 137

Evangelos Terpos

Evangelos Terpos

National and Kapodistrian University of Athens

Publications: 131

Irene M. Ghobrial

Irene M. Ghobrial

Harvard University

Publications: 124

Rafael Fonseca

Rafael Fonseca

Mayo Clinic

Publications: 120

Joan Bladé

Joan Bladé

University of Barcelona

Publications: 116

Trending Scientists

Behdad Moghtaderi

Behdad Moghtaderi

University of Newcastle Australia

Haralampos N. Miras

Haralampos N. Miras

University of Glasgow

Ke Wang

Ke Wang

Sichuan University

Sunil C. Kaul

Sunil C. Kaul

National Institute of Advanced Industrial Science and Technology

D. P. Poppi

D. P. Poppi

University of Queensland

Natalie Waran

Natalie Waran

Eastern Institute of Technology

Niels Bastian Kristensen

Niels Bastian Kristensen

Aarhus University

Jean-Luc Imler

Jean-Luc Imler

University of Strasbourg

Bernard Joris

Bernard Joris

University of Liège

Edwin H. Beachey

Edwin H. Beachey

University of Tennessee Health Science Center

Marin K. Clark

Marin K. Clark

University of Michigan–Ann Arbor

Falk Nimmerjahn

Falk Nimmerjahn

University of Erlangen-Nuremberg

Alexander I. Tröster

Alexander I. Tröster

Barrow Neurological Institute

Linda J. Skitka

Linda J. Skitka

University of Illinois at Chicago

J. D. Thompson

J. D. Thompson

Los Alamos National Laboratory

Kevin Krisciunas

Kevin Krisciunas

Texas A&M University

Something went wrong. Please try again later.